2Hay ID, Gonzalez-Losada T, Reinalda MS, et al. Long-term outcomes in 215 children and adoles- cents with papillary thyroid cancer treated during 1940 through 2008 [ J]. World J Surg, 2010, 34 (6): 1192-1202.
3Huang IC, Chou FF, Liu RT, et al. Long-term out- comes of distant metastasis from differentiated thyroid carcinoma [ J 1. Clin Endocrinol (Oxf), 2012, 76(3) : 439 -447.
4DeLellis RA, Loyd RV, Heitz PU, et al. Pathology and genetics of tumors of endocrine organs (IARC WHO Classification of Tumors ) [ M]. Pub- lisher: World Health Organization, 2004:58-71.
5Weber A, Schmid KW, Tannapfel A, et al. Chan- ges in the TNM classification of head and neck tumors[J]. Pathology, 2010, 31 (5): 339-343.
6Nixon I J, Ganly I, Palmer FL, et al. Disease-relat- ed death in patients who were considered free of macroscopic disease after initial treatment of well-differentiated thyroid carcinoma l J ]. Thyroid, 2011 , 21 (5) : 501 -504.
7Lianidou ES, Markou A, Strati A. Molecular char- acterization of circulating tumor cells in breast cancer: challenges and promises for individual- ized cancer treatment J ]. Cancer Metastasis Rev, 2012, 31 (4) : 663 -671.
8Bidard FC, Peeters D J, Fehm T, et al. Clinical validity of circulating tumor cells in patients with metastatic breast cancer: a pooled analysis of in- dividual patient data[J]. Lancet Oncol, 2014, 15 (4) : 406 -414.
9Noguchi S, Hiratsuka M, Furukawa H, et al. Detec- tion of gastric cancer micrometastases in lymph nodes by amplification of keratin 19 mRNA with re- verse transcriptase-polymerase chain reaction [ J ]. Jpn J Cancer Res, 1996, 87(6)- 650-654.
10Tunca B, Egeli U, Cecener G, et al. CK19, CK20, EGFR and HER2 status of circulating tumor cells in patients with breast cancer[J]. Tu- mori, 2012, 98(2) : 243 -251.
